These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Δ-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: involvement of cannabinoid receptor 2 and p38 MAPK. Yamaori S; Ishii H; Chiba K; Yamamoto I; Watanabe K Toxicology; 2013 Dec; 314(2-3):254-61. PubMed ID: 24184660 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation. Jeon YJ; Yang KH; Pulaski JT; Kaminski NE Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH). Baird SN; Frazee CC; Garg U J Appl Lab Med; 2023 Jul; 8(4):665-673. PubMed ID: 37071885 [TBL] [Abstract][Full Text] [Related]
5. MiR-21 inhibitor improves locomotor function recovery by inhibiting IL-6R/JAK-STAT pathway-mediated inflammation after spinal cord injury in model of rat. Ning SL; Zhu H; Shao J; Liu YC; Lan J; Miao J Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):433-440. PubMed ID: 30720148 [TBL] [Abstract][Full Text] [Related]
6. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Darmani NA; Johnson JC Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052 [TBL] [Abstract][Full Text] [Related]
7. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282 [TBL] [Abstract][Full Text] [Related]
8. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol. Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921 [TBL] [Abstract][Full Text] [Related]
9. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation. Ngaotepprutaram T; Kaplan BL; Carney S; Crawford R; Kaminski NE Toxicology; 2013 Aug; 310():84-91. PubMed ID: 23727458 [TBL] [Abstract][Full Text] [Related]
10. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells. Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917 [TBL] [Abstract][Full Text] [Related]
12. An Agathokakological Tale of Δ Mathew B; Harilal S; Musa A; Kumar R; Parambi DGT; Jose J; Uddin MS; Shah MA; Behl T; Unnikrishnan MK Curr Drug Targets; 2021; 22(7):823-834. PubMed ID: 33001012 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the Jak/STAT signaling pathway. Song Y; Zeng Z; Jin C; Zhang J; Ding B; Zhang F Neurochem Res; 2013 Mar; 38(3):610-9. PubMed ID: 23274522 [TBL] [Abstract][Full Text] [Related]
14. Review of delta-8-tetrahydrocannabinol (Δ Tagen M; Klumpers LE Br J Pharmacol; 2022 Aug; 179(15):3915-3933. PubMed ID: 35523678 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037 [TBL] [Abstract][Full Text] [Related]
16. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Takeda S; Yamamoto I; Watanabe K Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940 [TBL] [Abstract][Full Text] [Related]
17. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780 [TBL] [Abstract][Full Text] [Related]
18. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells. Ngaotepprutaram T; Kaplan BL; Kaminski NE Toxicol Appl Pharmacol; 2013 Nov; 273(1):209-18. PubMed ID: 23999542 [TBL] [Abstract][Full Text] [Related]
19. Emergence of the less common cannabinoid Δ Rzeppa S; Große J; Rautenberg C; Thieme D; Lepp T; Vallimäe H; Keiler AM Drug Test Anal; 2021 Nov; 13(11-12):1936-1943. PubMed ID: 34494719 [TBL] [Abstract][Full Text] [Related]